title: Fatal ergotism induced by an HIV protease inhibitor.
authors.forename: Marc A
authors.initials: MA
authors.lastname: Tribble
authors.forename: Clark R
authors.initials: CR
authors.lastname: Gregg
authors.forename: David M
authors.initials: DM
authors.lastname: Margolis
authors.forename: Robin
authors.initials: R
authors.lastname: Amirkhan
authors.forename: James W
authors.initials: JW
authors.lastname: Smith
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000188:drug therapy*; D002110:Caffeine / Q000009:adverse effects* / Q000627:therapeutic use; D004338:Drug Combinations; D004347:Drug Interactions; D004878:Ergotamine / Q000009:adverse effects* / Q000627:therapeutic use; D004881:Ergotism / Q000209:etiology*; D017809:Fatal Outcome; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006261:Headache / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D020925:Hypoxia-Ischemia, Brain / Q000139:chemically induced; D008297:Male; D008875:Middle Aged
chemical_list: D004338:Drug Combinations; D017320:HIV Protease Inhibitors; C037330:caffeine, ergotamine drug combination; D002110:Caffeine; D004878:Ergotamine